S2Medical AB
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and… Read more
S2Medical AB (S2M) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.068x
Based on the latest financial reports, S2Medical AB (S2M) has a cash flow conversion efficiency ratio of 0.068x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr1.29 Million) by net assets (Skr18.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
S2Medical AB - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how S2Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
S2Medical AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of S2Medical AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wisconsin Electric Power Company PFD 3.60%
OTCQB:WELPP
|
0.048x |
|
ECG-WI
NYSE:ECG-WI
|
N/A |
|
Yuhan Corp. Pfd. Series 1
KQ:000105
|
N/A |
|
AMADEUS IT HOLD -A-
BE:AI3A
|
0.093x |
|
NEW YORK TIMES -A- - Dusseldorf Stock Exchang
DU:NYT
|
0.068x |
|
Bitcoin Fund Unit
TO:QBTC
|
-0.019x |
|
TRIMBLE NAVIGATION
BE:TB5
|
0.022x |
|
Twin Vee Powercats Co
NASDAQ:VEEE
|
-0.166x |
Annual Cash Flow Conversion Efficiency for S2Medical AB (2016–2025)
The table below shows the annual cash flow conversion efficiency of S2Medical AB from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr9.88 Million | Skr675.00K | 0.068x | -83.97% |
| 2024-12-31 | Skr11.80 Million | Skr5.03 Million | 0.426x | +104.28% |
| 2023-12-31 | Skr1.66 Million | Skr-16.52 Million | -9.964x | -150.39% |
| 2022-12-31 | Skr7.07 Million | Skr-28.13 Million | -3.979x | -197.08% |
| 2021-12-31 | Skr14.68 Million | Skr-19.67 Million | -1.339x | -244.25% |
| 2020-12-31 | Skr32.77 Million | Skr-12.75 Million | -0.389x | +42.87% |
| 2019-12-31 | Skr25.11 Million | Skr-17.10 Million | -0.681x | -132.57% |
| 2018-12-31 | Skr43.55 Million | Skr-12.75 Million | -0.293x | +63.05% |
| 2017-12-31 | Skr7.38 Million | Skr-5.85 Million | -0.793x | +28.05% |
| 2016-12-31 | Skr2.75 Million | Skr-3.03 Million | -1.102x | -- |